穿皮冠状动脉干预后死亡原因的趋势
Daniel B Spoon1, Peter J Psaltis, Mandeep Singh
1Divisions of Cardiovascular Diseases (D.B.S., P.J.P., M.S., D.R.H., B.J.G., C.S.R., R.D.S., R.G.) and Biomedical Statistics and Informatics (R.J.L.), Mayo Clinic, Rochester, MN; and Division of Cardiovascular Diseases (I.D.M.), Mayo Clinic, Jacksonville, FL.
Circulation
|February 12, 2014
概括
在过去的二十年中,穿皮冠状动脉干预 (PCI) 后的死亡率从心脏原因转移到癌症等非心脏原因. 这一趋势无论患者的特征如何,都会发生,突出显示PCI后死亡率模式的变化.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 公共卫生 公共卫生
背景情况:
- 穿皮冠状动脉干预 (PCI) 后的长期死亡原因尚未完全理解,特别是随着患者人口结构的变化.
- 了解这些趋势对于改善患者治疗结果和医疗保健策略至关重要.
研究的目的:
- 评估PCI后特定原因长期死亡率的时间趋势.
- 确定二十年来死亡原因的变化及其与患者特征的关系.
主要方法:
- 一项单中心研究分析了1991年至2008年接受PCI的19077名患者,随访时间为2012年.
- 特定原因死亡率通过前性监测,采访,医疗记录和死亡证明来确定.
- 竞争风险分析比较了三个PCI时期的死亡率:1991-1996,1997-2002年和2003-2008年.
主要成果:
- 在PCI后5年的心脏病死亡人数下降了33% (9.8%至6.6%),而非心脏病死亡人数在研究期间增加了57% (7.1%至11.2%).
- 在最近的时代,只有36.8%的死亡是与心脏有关的.
- 经过调整后的分析显示,心脏病死亡率下降了50%,但非心脏病死亡率没有变化,由癌症和慢性疾病驱动的增加.
结论:
- 在PCI后的死亡原因中,从心脏到非心脏的死亡原因的显著时间转移在20年内被观察到.
- 心脏病死亡率的降低独立于患者的基线特征.
- 这些发现需要对PCI后护理策略和临床试验设计进行重新评估,以解决非心脏病死亡率的问题.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495


